======= GALR2 ======= == Gene Information == * **Official Symbol**: GALR2 * **Official Name**: galanin receptor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8811|8811]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43603|O43603]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GALR2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GALR2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603691|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Receptor for the hormone galanin and GALP. Receptor for the hormone spexin-1 (PubMed:24517231). The activity of this receptor is mediated by G proteins that activate the phospholipase C/protein kinase C pathway (via G(q)) and that inhibit adenylyl cyclase (via G(i)). {ECO:0000269|PubMed:24517231, ECO:0000269|PubMed:25691535, ECO:0000269|PubMed:9480833, ECO:0000269|PubMed:9685625, ECO:0000269|PubMed:9832121, ECO:0000269|PubMed:9880084}. |7tm 1| |7TM GPCR Srsx| |positive regulation of large conductance calcium-activated potassium channel activity| |galanin-activated signaling pathway| |regulation of large conductance calcium-activated potassium channel activity| |galanin receptor activity| |negative regulation of adenylate cyclase activity| |negative regulation of cyclase activity| |negative regulation of lyase activity| |neuropeptide binding| |positive regulation of potassium ion transmembrane transporter activity| |regulation of adenylate cyclase activity| |positive regulation of potassium ion transmembrane transport| |G protein-coupled peptide receptor activity| |peptide hormone binding| |regulation of cyclase activity| |positive regulation of potassium ion transport| |regulation of lyase activity| |regulation of potassium ion transmembrane transporter activity| |inositol phosphate metabolic process| |positive regulation of cation channel activity| |regulation of potassium ion transmembrane transport| |feeding behavior| |phospholipase C-activating G protein-coupled receptor signaling pathway| |regulation of potassium ion transport| |positive regulation of ion transmembrane transporter activity| |neuropeptide signaling pathway| |polyol metabolic process| |positive regulation of transporter activity| |adenylate cyclase-activating G protein-coupled receptor signaling pathway| |positive regulation of cation transmembrane transport| |cAMP-mediated signaling| |positive regulation of ion transmembrane transport| |phosphatidylinositol metabolic process| |regulation of cation channel activity| |cyclic-nucleotide-mediated signaling| |cilium| |positive regulation of transmembrane transport| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |muscle contraction| |regulation of ion transmembrane transporter activity| |learning or memory| |regulation of transmembrane transporter activity| |positive regulation of ion transport| |regulation of transporter activity| |positive regulation of cytosolic calcium ion concentration| |cognition| |muscle system process| |glycerophospholipid metabolic process| |alcohol metabolic process| |regulation of cytosolic calcium ion concentration| |regulation of cation transmembrane transport| |second-messenger-mediated signaling| |phospholipid metabolic process| |glycerolipid metabolic process| |regulation of metal ion transport| |cellular calcium ion homeostasis| |calcium ion homeostasis| |organic hydroxy compound metabolic process| |cellular divalent inorganic cation homeostasis| |regulation of ion transmembrane transport| |divalent inorganic cation homeostasis| |cellular metal ion homeostasis| |regulation of transmembrane transport| |behavior| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |neuron projection development| |regulation of ion transport| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |ion homeostasis| |negative regulation of catalytic activity| |neuron development| |organophosphate metabolic process| |cellular homeostasis| |cellular lipid metabolic process| |positive regulation of transport| |neuron differentiation| |chemical homeostasis| |plasma membrane bounded cell projection organization| |negative regulation of molecular function| |cell projection organization| |lipid metabolic process| |positive regulation of transcription by RNA polymerase II| |G protein-coupled receptor signaling pathway| |nervous system process| |integral component of plasma membrane| |generation of neurons| |positive regulation of transcription, DNA-templated| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |cell development| |intracellular signal transduction| |positive regulation of RNA metabolic process| |small molecule metabolic process| |positive regulation of molecular function| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp332|Adefovir 20μM R07 exp332]]|-1.89| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|-1.72| |[[:results:exp151|SGC0946 7μM R03 exp151]]|-1.71| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15922 * **Expression level (log2 read counts)**: -2.84 {{:chemogenomics:nalm6 dist.png?nolink |}}